Medical research

PrEP implant that protects against HIV could be near

Animal research is pointing toward a new way to prevent HIV infection: a refillable implant that continuously delivers antiretroviral medications for up to 20 months at a time.

Medications

Second-line switch to dolutegravir noninferior in HIV

For patients with HIV without genotype information, a second-line switch to dolutegravir is noninferior to a regimen containing a ritonavir-boosted protease inhibitor (PI), according to a study published in the June 22 issue ...

HIV & AIDS

Meningococcal disease cases up in persons with HIV in 2022

In 2022, there was an increase in meningococcal disease among persons with HIV, with 29 cases reported, accounting for 9.8 percent of all meningococcal disease cases, according to research published in the June 16 issue of ...

page 18 from 415